ACT

MAY 21/2019


Advertisement

news roundup

Circuit Clinical and CUBRC Announce Partnership

Circuit Clinical has announced a partnership with CUBRC that utilizes Circuit Clinical's physician network and its patient engagement platform with CUBRC's knowledge in data sciences and the development and deployment of analytical software tools.


Advertisement

Operational Challenges in Resourcing and Executing Seasonal Infectious Diseases Studies
North America: Thursday, June 13, 2019 at 11am EDT | 10am CDT | 8am PDT
Register now


Still A Rocky Road for Biosimilars in the US

GlobalData outlines reasons why biosimilar development is lagging in the United States, particularly because of biosimilar companies' inability to provide competitive enough discounts to payers.


Advertisement

Operational Challenges in Resourcing and Executing Seasonal Infectious Diseases Studies
Europe: Thursday, June 6, 2019 at 3pm BST | 4pm CEST
Register now


Clinerion Collaborates on Patient Participation in Mexico

Inpharamo, a subsidiary of Semicrol, has signed a collaboration agreement with Clinerion to optimize the identification of patients who are candidates for participation in clinical trials in Mexico.


Advertisement

Refocusing on Risk Mitigation in Starting Clinical Trials
Tuesday, May 28, 2019 at 1pm EDT | 12pm CDT | 10am PDT
Register now


Elligo Health Research Launches its Clinical Technology

Elligo Health Research has announced the launch of its IntElligo Research Stack clinical technology. The standards-based technology platform will launch later this month as the eSource documentation tool at Elligo's Research Ready network of study sites.


Advertisement

Challenges in Biosimilar Bioanalytical Assays and Sample Processing
Tuesday, May 21, 2019 at 2:30pm IST | 5pm CST | 6pm JST
Register now


Articles

Latest Business News and People Moves

Read the latest updated business news and people moves for May.


Advertisement

A new way to assess changes in trial complexity, success and duration: The Clinical Development Productivity Index
Tuesday, May 21, 2019 at 11am EDT
Register now


The Right "EASY" Button Approach for RBM

This articles looks at the different ways to approach RBM and evaluates them for ease based on their process and effectiveness.


Advertisement

Challenges in Biosimilar Bioanalytical Assays and Sample Processing
On Demand
Learn More

advertisement

In this edition

Take this Tufts CSDD Survey on The Vendor Qualification Process!
The Right "EASY" Button Approach for RBM
Still A Rocky Road for Biosimilars in the US
advertisement

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »

Advertisement

Standardization Drives Transparency and Optimization of Contract/Budget Processes in Clinical Trial Startup
On Demand
Learn More


Events

4th Annual Managed Access Programs and Accelerated Pathways
BIO International Convention
Rare Disease Innovation and Partnering Summit
DIA 2019 Global Annual Meeting
Direct-to-Patient Trials
Search Upcoming Events

Blog Posts

Non-Pharmacological Approaches in Alzheimer's Treatment

The importance of non-pharmacological treatments becomes more criticial with the latest failures in Alzheimer's drug development.


Advertisement

Technology: Friend vs Foe - Considerations for Practical Execution of a Risk-Based Monitoring Strategy
On Demand
Learn More


Take this Tufts CSDD Survey on The Vendor Qualification Process!



Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise

Todd Baker
Group Publisher
TBaker@mmhgroup.com